Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope

  • J Immunol. 2009 Jul 1;183(1):430-7. doi: 10.4049/jimmunol.0900556.
Stéphanie Gras  1 ,  Xavier Saulquin ,  Jean-Baptiste Reiser ,  Emilie Debeaupuis ,  Klara Echasserieau ,  Adrien Kissenpfennig ,  François Legoux ,  Anne Chouquet ,  Madalen Le Gorrec ,  Paul Machillot ,  Bérangère Neveu ,  Nicole Thielens ,  Bernard Malissen ,  Marc Bonneville ,  Dominique Housset
Affiliations
  • 1. Institut de Biologie Structurale Jean-Pierre Ebel, CEA, CNRS, UJF, PSB, Grenoble, France.
Abstract

Protective T cell responses elicited along chronic human CMV (HCMV) infections are sometimes dominated by CD8 T cell clones bearing highly related or identical public TCR in unrelated individuals. To understand the principles that guide emergence of these public T cell responses, we have performed structural, biophysical, and functional analyses of an immunodominant public TCR (RA14) directed against a major HLA-A*0201-restricted HCMV Ag (pp65(495-503)) and selected in vivo from a diverse repertoire after chronic stimulations. Unlike the two immunodominant public TCRs crystallized so far, which focused on one peptide hotspot, the HCMV-specific RA14 TCR interacts with the full array of available peptide residues. The conservation of some peptide-MHC complex-contacting Amino acids by lower-affinity TCRs suggests a shared TCR-peptide-MHC complex docking mode and supports an Ag-driven selection of optimal TCRs. Therefore, the emergence of a public TCR of an oligoclonal Ag-specific response after repeated viral stimulations is based on a receptor displaying a high structural complementarity with the entire peptide and focusing on three peptide hotspots. This highlights key parameters underlying the selection of a protective T cell response against HCMV Infection, which remains a major health issue in patients undergoing bone marrow transplantation.